| Identification | Back Directory | [Name]
Benzamide, N-[[4-[5-[3-(acetylamino)phenyl]-2-(2-amino-3-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]phenyl]methyl]-3-fluoro- | [CAS]
1313880-28-2 | [Synonyms]
Benzamide, N-[[4-[5-[3-(acetylamino)phenyl]-2-(2-amino-3-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]phenyl]methyl]-3-fluoro- | [Molecular Formula]
C33H26FN7O2 | [MOL File]
1313880-28-2.mol | [Molecular Weight]
571.6 |
| Hazard Information | Back Directory | [Uses]
AKT-IN-22 (compound 0R4) is a potent AKT allosteric inhibitor with anticancer effects[1]. | [References]
[1] Karunakaran K, et al. Integrating machine learning and high throughput screening for the discovery of allosteric AKT1 inhibitors. J Biomol Struct Dyn. 2023 Dec 14:1-22. DOI:10.1080/07391102.2023.2293265 |
|
|